NFKB1 and hematopoietic and lymphoid system neoplasm: Among these molecular targets, ABCB1 (r = 0.53, p = 0.02), ABCC1 (r = 0.67, p = 0.001), p-AKT (r = 0.53, p = 0.02), p-NFκB (r = 0.80, p < 0.0001), and NFκB (r = 0.81, p < 0.0001) were associated with IC50 values for eribulin in the blood cancer cell lines (Figure 7D).